ClinicalTrials.gg
Not yet recruitingNCT07630025T2DUpdated Jun 5, 2026

Concurrent Exercise Training

An interventional study of Exercise and exercise in Typ 2 Diabetes, sponsored by Prince Sattam Bin Abdulaziz University. Not yet recruiting. Open to male participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-06-05.

Sponsored by Prince Sattam Bin Abdulaziz University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
Male
01

Study summary

The goal of this clinical trial is to investigate the influence of morning versus evening concurrent training consisting of high-intensity interval training and resistance training on glycemic control in men with type 2 diabetes mellitus. The main questions it aims to answer are:

  • Which time is best for concurrent exercise training in diabetic patients, morning or evening? Researchers will compare morning versus evening concurrent training consisting of HIIT and RT on glycemic control in men with type 2 diabetes mellitus.

Participants will:

  • Perform concurrent training consisting of high-intensity interval training and resistance training for 12 weeks
  • Visit the clinic before and after the 12-week experimental period for checkups and tests
02

Conditions studied

  • Typ 2 Diabetes

Browse trials for

Keywords

  • Diabetes
  • High Intensity Interval Trainin
  • resistance trsaining
  • glycemic control
03

In context

Diabetes Mellitus

8,290 studies on the registry are indexed under Diabetes Mellitus; 1,077 are open to participants now.

This study's planned enrollment of 60 is below the median of 80 across 6,023 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Prince Sattam Bin Abdulaziz University is the lead sponsor of 35 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
Male
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • men aged 40-60 years with a diagnosis of T2D
  • levels between 7.0% and 9.0%
  • treatment with oral hypoglycemic agents for at least 6 months
  • a \<30 kg/m²
  • a physically inactive

Exclusion criteria

Exclusion Criteria:

  • current insulin therapy
  • a cardiovascular event within the previous 6 months
  • cardiovascular, respiratory or musculoskeletal conditions that could limit participation in exercise training
  • body weight instability
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Morning concurrent training (amCT)

    will perform combined HIIT and RT between 06:00 and 09:00

    Behavioral: Exercise

  • Experimental
    Evening concurrent training (pmCT)

    will perform combined HIIT and RT between 16:00 and 19:00

    Behavioral: exercise

  • No intervention
    The control group (CON)

    no exercise program

Interventions

  • BehavioralExercise

    Morning concurrent high-intensity interval training and resistance training

  • Behavioralexercise

    evening concurrent high-intensity interval training and resistance training between 16:00 and 19:00

06

What researchers measure

Primary outcomes

  1. glycemic control

    HbA1c

    Time frame: baseline and at 12 weeks.

Secondary outcomes

  1. lipid profile

    total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides

    Time frame: baseline and at 12 weeks

  2. cardiorespiratory fitness

    VO2peak

    Time frame: at baseline and at 12 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Yes — on request from the PA

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07630025
Lead sponsor
Prince Sattam Bin Abdulaziz University
Responsible party
Ahmad Saied Mohammad (Dr, Prince Sattam Bin Abdulaziz University) — Principal investigator
First posted
Jun 5, 2026
Start date
Jun 2026 (estimated)
Primary completion
Sep 2026 (estimated)
Completion
Oct 2026 (estimated)
Last update
Jun 5, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion